Fig. 1From: Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practiceEconomic impact (cost items), excluding the related costs for HCV therapy, in HIV+ and HIV/HCV populations, with one comorbidityBack to article page